Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.NANX · Entity 7041 | Director | December 20, 2022 | December 22, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date December 20, 2022 · Filed December 22, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2023-02-14 | Direct | 0 |
Reported balance
After 2022-11-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-11-15 · Exercise / conversion · Disposed 10,000 · Balance 0 F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2029-12-20 | Direct | 15,000 |
Reported balance
After 2022-12-20 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2022-12-20 · Grant · Acquired 15,000 · Balance 15,000 F5: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.52 · Expires 2024-02-13 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 10,000 F5: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.44 · Expires 2025-02-18 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 9,000 F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2026-02-23 | Direct | 8,100 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 8,100 F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.90 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.05 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.18 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.84 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.99 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 2,000 F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.68 · Expires 2027-02-21 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 10,000 F5: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2028-05-23 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 10,000 F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2029-05-22 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 10,000 F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.45 · Expires 2027-06-18 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 15,000 F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $4.17 · Expires 2028-12-28 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 15,000 F5: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. |
| Common StockSEC Table I · non-derivative | Direct | 409,838 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 409,838 |
| Deferred Common StockSEC Table II · derivative / convertible security | Direct | 20,030 |
Reported balance
Holding disclosure · report date 2022-12-20 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 20,030 F1: Each share of deferred common stock represents a right to receive one share of common stock. F2: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company. F3: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of deferred common stock represents a right to receive one share of common stock.
F2: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F3: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
F4: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
F5: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.
F6: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2022 Filed Dec 22, 2022 16:20 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 15,000 | $1.17 Strike: $1.17 | $17,475.00 |
DisclosureSEC source: 0001209191-22-062389 · doc4.xml · derivative · entry 19 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-12-20 F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. Read SEC document |
| November 15, 2022 Filed Dec 19, 2022 21:18 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 10,000 | $0.42 Strike: $0.42 | $4,150.00 |
DisclosureSEC source: 0001209191-22-061888 · doc4.xml · derivative · entry 4 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 15, 2022 Filed Dec 19, 2022 21:18 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 10,000 | $0.42 | $4,150.00 |
DisclosureSEC source: 0001209191-22-061888 · doc4.xml · nonDerivative · entry 2 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Dec 22, 2022 16:20 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 10,000 | $0.42 Strike: $0.42 | $4,150.00 |
DisclosureSEC source: 0001209191-22-062389 · doc4.xml · derivative · entry 3 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| July 21, 2022 Filed Jul 25, 2022 20:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 10,000 | $0.30 Strike: $0.30 | $3,000.00 |
DisclosureSEC source: 0001209191-22-043088 · doc4.xml · derivative · entry 4 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| July 21, 2022 Filed Jul 25, 2022 20:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 10,000 | $0.30 | $3,000.00 |
DisclosureSEC source: 0001209191-22-043088 · doc4.xml · nonDerivative · entry 2 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 18:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 15,000 | $4.17 Strike: $4.17 | $62,550.00 |
DisclosureSEC source: 0001209191-21-071587 · doc4.xml · derivative · entry 19 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-12-28 F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. Read SEC document |
| December 28, 2021 Filed Jul 25, 2022 20:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 15,000 | $4.17 Strike: $4.17 | $62,550.00 |
DisclosureSEC source: 0001209191-22-043088 · doc4.xml · derivative · entry 20 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-12-28 F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 21:47 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 15,000 | $0.45 Strike: $0.45 | $6,750.00 |
DisclosureSEC source: 0001209191-20-038018 · doc4.xml · derivative · entry 19 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-18 F1 · derivative.exercise_date: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 22, 2019 Filed May 30, 2019 20:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 10,000 | $0.51 Strike: $0.51 | $5,100.00 |
DisclosureSEC source: 0001209191-19-033420 · doc4.xml · derivative · entry 17 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 22, 2019 Filed Jun 3, 2019 14:16 UTC Amendment | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 10,000 | $0.51 Strike: $0.51 | $5,100.00 |
DisclosureSEC source: 0001209191-19-033777 · doc4a.xml · derivative · entry 18 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-22 F1 · derivative.exercise_date: Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 23, 2018 Filed May 24, 2018 22:26 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 10,000 | $0.82 Strike: $0.82 | $8,200.00 |
DisclosureSEC source: 0001209191-18-033132 · doc4.xml · derivative · entry 17 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-05-23 F5 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:21 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.68 Strike: $0.68 | $6,800.00 |
DisclosureSEC source: 0001209191-17-013419 · doc4.xml · derivative · entry 16 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-02-21 F5 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.99 Strike: $0.99 | $1,980.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 16 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.10 Strike: $1.10 | $2,200.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 15 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.85 Strike: $1.85 | $3,700.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 14 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.84 Strike: $0.84 | $1,680.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 13 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.18 Strike: $1.18 | $2,360.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 12 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.05 Strike: $1.05 | $2,100.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 11 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.90 Strike: $0.90 | $1,800.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 10 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | Disposition to issuerStock Appreciation Right · Derivative | 14,000 | $1.18 Strike: $1.18 | $16,520.00 |
DisclosureSEC source: 0001209191-16-151349 · doc4.xml · derivative · entry 4 SIEGEL RICHARD W · CIK 0001195154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires not disclosed F5 · security: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.exercise_price: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.exercise_date: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.expiration_date: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.